Activation of autophagy in macrophages by pro-resolving lipid mediators

The resolution of inflammation is an active process driven by specialized pro-resolving lipid mediators, such as 15-epi-LXA 4 and resolvin D1 (RvD1), that promote tissue regeneration. Macrophages regulate the innate immune response being key players during the resolution phase to avoid chronic infla...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Autophagy 2015-10, Vol.11 (10), p.1729-1744
Hauptverfasser: Prieto, Patricia, Rosales-Mendoza, César Eduardo, Terrón, Verónica, Toledano, Víctor, Cuadrado, Antonio, López-Collazo, Eduardo, Bannenberg, Gerard, Martín-Sanz, Paloma, Fernández-Velasco, María, Boscá, Lisardo
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1744
container_issue 10
container_start_page 1729
container_title Autophagy
container_volume 11
creator Prieto, Patricia
Rosales-Mendoza, César Eduardo
Terrón, Verónica
Toledano, Víctor
Cuadrado, Antonio
López-Collazo, Eduardo
Bannenberg, Gerard
Martín-Sanz, Paloma
Fernández-Velasco, María
Boscá, Lisardo
description The resolution of inflammation is an active process driven by specialized pro-resolving lipid mediators, such as 15-epi-LXA 4 and resolvin D1 (RvD1), that promote tissue regeneration. Macrophages regulate the innate immune response being key players during the resolution phase to avoid chronic inflammatory pathologies. Their half-life is tightly regulated to accomplish its phagocytic function, allowing the complete cleaning of the affected area. The balance between apoptosis and autophagy appears to be essential to control the survival of these immune cells within the inflammatory context. In the present work, we demonstrate that 15-epi-LXA 4 and RvD1 at nanomolar concentrations promote autophagy in murine and human macrophages. Both compounds induced the MAP1LC3-I to MAP1LC3-II processing and the degradation of SQSTM1 as well as the formation of MAP1LC3 + autophagosomes, a typical signature of autophagy. Furthermore, 15-epi-LXA 4 and RvD1 treatment favored the fusion of the autophagosomes with lysosomes, allowing the final processing of the autophagic vesicles. This autophagic response involves the activation of MAPK1 and NFE2L2 pathways, but by an MTOR-independent mechanism. Moreover, these pro-resolving lipids improved the phagocytic activity of macrophages via NFE2L2. Therefore, 15-epi-LXA 4 and RvD1 improved both survival and functionality of macrophages, which likely supports the recovery of tissue homeostasis and avoiding chronic inflammatory diseases.
doi_str_mv 10.1080/15548627.2015.1078958
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1080_15548627_2015_1078958</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1728257110</sourcerecordid><originalsourceid>FETCH-LOGICAL-c534t-aee34bc0cc1e8be63af3906d1ccffb77e0a16b22f4dbe68586e2007aca3390573</originalsourceid><addsrcrecordid>eNp9UctOwzAQtBAIyuMTQDlyCfgRx-4FgSooSJW4wNnaOHYxSuJgp0X9e1xaKrhw2tfszGoHoXOCrwiW-JpwXsiSiiuKCU8tIcdc7qHRup_LkvH9XU7FETqO8R1jVsoxPURHtOR4nY7Q9E4PbgmD813mbQaLwfdvMF9lrsta0OG7MjGrVlkffB5M9M3SdfOscb2rs9bUDgYf4ik6sNBEc7aNJ-j14f5l8pjPnqdPk7tZrjkrhhyMYUWlsdbEyMqUDCwb47ImWltbCWEwkLKi1BZ1mkouS0MxFqCBJRwX7ATdbHj7RZXEtemGAI3qg2shrJQHp_5OOvem5n6pCkkLPi4SweWWIPiPhYmDal3UpmmgM34RFRFUUi4IwQnKN9D0hhiDsTsZgtXaBPVjglqboLYmpL2L3zfutn6-ngC3G4DrrA8tfPrQ1GqAVeODDdBpFxX7X-MLCpeY6w</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1728257110</pqid></control><display><type>article</type><title>Activation of autophagy in macrophages by pro-resolving lipid mediators</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Prieto, Patricia ; Rosales-Mendoza, César Eduardo ; Terrón, Verónica ; Toledano, Víctor ; Cuadrado, Antonio ; López-Collazo, Eduardo ; Bannenberg, Gerard ; Martín-Sanz, Paloma ; Fernández-Velasco, María ; Boscá, Lisardo</creator><creatorcontrib>Prieto, Patricia ; Rosales-Mendoza, César Eduardo ; Terrón, Verónica ; Toledano, Víctor ; Cuadrado, Antonio ; López-Collazo, Eduardo ; Bannenberg, Gerard ; Martín-Sanz, Paloma ; Fernández-Velasco, María ; Boscá, Lisardo</creatorcontrib><description>The resolution of inflammation is an active process driven by specialized pro-resolving lipid mediators, such as 15-epi-LXA 4 and resolvin D1 (RvD1), that promote tissue regeneration. Macrophages regulate the innate immune response being key players during the resolution phase to avoid chronic inflammatory pathologies. Their half-life is tightly regulated to accomplish its phagocytic function, allowing the complete cleaning of the affected area. The balance between apoptosis and autophagy appears to be essential to control the survival of these immune cells within the inflammatory context. In the present work, we demonstrate that 15-epi-LXA 4 and RvD1 at nanomolar concentrations promote autophagy in murine and human macrophages. Both compounds induced the MAP1LC3-I to MAP1LC3-II processing and the degradation of SQSTM1 as well as the formation of MAP1LC3 + autophagosomes, a typical signature of autophagy. Furthermore, 15-epi-LXA 4 and RvD1 treatment favored the fusion of the autophagosomes with lysosomes, allowing the final processing of the autophagic vesicles. This autophagic response involves the activation of MAPK1 and NFE2L2 pathways, but by an MTOR-independent mechanism. Moreover, these pro-resolving lipids improved the phagocytic activity of macrophages via NFE2L2. Therefore, 15-epi-LXA 4 and RvD1 improved both survival and functionality of macrophages, which likely supports the recovery of tissue homeostasis and avoiding chronic inflammatory diseases.</description><identifier>ISSN: 1554-8627</identifier><identifier>ISSN: 1554-8635</identifier><identifier>EISSN: 1554-8635</identifier><identifier>DOI: 10.1080/15548627.2015.1078958</identifier><identifier>PMID: 26506892</identifier><language>eng</language><publisher>United States: Taylor &amp; Francis</publisher><subject>15-epi-lipoxin-A ; Animals ; Apoptosis - physiology ; Autophagy - genetics ; Autophagy - physiology ; Basic Research Papers ; Cytokines - metabolism ; Docosahexaenoic Acids - metabolism ; Half-Life ; inflammation ; Inflammation - metabolism ; Lipoxins - metabolism ; Macrophages - cytology ; macrophages resolution ; Mice, Inbred BALB C ; Mice, Inbred C57BL ; Mice, Knockout ; resolvin-D1</subject><ispartof>Autophagy, 2015-10, Vol.11 (10), p.1729-1744</ispartof><rights>2015 Taylor &amp; Francis Group, LLC 2015</rights><rights>2015 Taylor &amp; Francis Group, LLC 2015 Taylor &amp; Francis Group, LLC</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c534t-aee34bc0cc1e8be63af3906d1ccffb77e0a16b22f4dbe68586e2007aca3390573</citedby><cites>FETCH-LOGICAL-c534t-aee34bc0cc1e8be63af3906d1ccffb77e0a16b22f4dbe68586e2007aca3390573</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4824594/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4824594/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26506892$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Prieto, Patricia</creatorcontrib><creatorcontrib>Rosales-Mendoza, César Eduardo</creatorcontrib><creatorcontrib>Terrón, Verónica</creatorcontrib><creatorcontrib>Toledano, Víctor</creatorcontrib><creatorcontrib>Cuadrado, Antonio</creatorcontrib><creatorcontrib>López-Collazo, Eduardo</creatorcontrib><creatorcontrib>Bannenberg, Gerard</creatorcontrib><creatorcontrib>Martín-Sanz, Paloma</creatorcontrib><creatorcontrib>Fernández-Velasco, María</creatorcontrib><creatorcontrib>Boscá, Lisardo</creatorcontrib><title>Activation of autophagy in macrophages by pro-resolving lipid mediators</title><title>Autophagy</title><addtitle>Autophagy</addtitle><description>The resolution of inflammation is an active process driven by specialized pro-resolving lipid mediators, such as 15-epi-LXA 4 and resolvin D1 (RvD1), that promote tissue regeneration. Macrophages regulate the innate immune response being key players during the resolution phase to avoid chronic inflammatory pathologies. Their half-life is tightly regulated to accomplish its phagocytic function, allowing the complete cleaning of the affected area. The balance between apoptosis and autophagy appears to be essential to control the survival of these immune cells within the inflammatory context. In the present work, we demonstrate that 15-epi-LXA 4 and RvD1 at nanomolar concentrations promote autophagy in murine and human macrophages. Both compounds induced the MAP1LC3-I to MAP1LC3-II processing and the degradation of SQSTM1 as well as the formation of MAP1LC3 + autophagosomes, a typical signature of autophagy. Furthermore, 15-epi-LXA 4 and RvD1 treatment favored the fusion of the autophagosomes with lysosomes, allowing the final processing of the autophagic vesicles. This autophagic response involves the activation of MAPK1 and NFE2L2 pathways, but by an MTOR-independent mechanism. Moreover, these pro-resolving lipids improved the phagocytic activity of macrophages via NFE2L2. Therefore, 15-epi-LXA 4 and RvD1 improved both survival and functionality of macrophages, which likely supports the recovery of tissue homeostasis and avoiding chronic inflammatory diseases.</description><subject>15-epi-lipoxin-A</subject><subject>Animals</subject><subject>Apoptosis - physiology</subject><subject>Autophagy - genetics</subject><subject>Autophagy - physiology</subject><subject>Basic Research Papers</subject><subject>Cytokines - metabolism</subject><subject>Docosahexaenoic Acids - metabolism</subject><subject>Half-Life</subject><subject>inflammation</subject><subject>Inflammation - metabolism</subject><subject>Lipoxins - metabolism</subject><subject>Macrophages - cytology</subject><subject>macrophages resolution</subject><subject>Mice, Inbred BALB C</subject><subject>Mice, Inbred C57BL</subject><subject>Mice, Knockout</subject><subject>resolvin-D1</subject><issn>1554-8627</issn><issn>1554-8635</issn><issn>1554-8635</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9UctOwzAQtBAIyuMTQDlyCfgRx-4FgSooSJW4wNnaOHYxSuJgp0X9e1xaKrhw2tfszGoHoXOCrwiW-JpwXsiSiiuKCU8tIcdc7qHRup_LkvH9XU7FETqO8R1jVsoxPURHtOR4nY7Q9E4PbgmD813mbQaLwfdvMF9lrsta0OG7MjGrVlkffB5M9M3SdfOscb2rs9bUDgYf4ik6sNBEc7aNJ-j14f5l8pjPnqdPk7tZrjkrhhyMYUWlsdbEyMqUDCwb47ImWltbCWEwkLKi1BZ1mkouS0MxFqCBJRwX7ATdbHj7RZXEtemGAI3qg2shrJQHp_5OOvem5n6pCkkLPi4SweWWIPiPhYmDal3UpmmgM34RFRFUUi4IwQnKN9D0hhiDsTsZgtXaBPVjglqboLYmpL2L3zfutn6-ngC3G4DrrA8tfPrQ1GqAVeODDdBpFxX7X-MLCpeY6w</recordid><startdate>20151003</startdate><enddate>20151003</enddate><creator>Prieto, Patricia</creator><creator>Rosales-Mendoza, César Eduardo</creator><creator>Terrón, Verónica</creator><creator>Toledano, Víctor</creator><creator>Cuadrado, Antonio</creator><creator>López-Collazo, Eduardo</creator><creator>Bannenberg, Gerard</creator><creator>Martín-Sanz, Paloma</creator><creator>Fernández-Velasco, María</creator><creator>Boscá, Lisardo</creator><general>Taylor &amp; Francis</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20151003</creationdate><title>Activation of autophagy in macrophages by pro-resolving lipid mediators</title><author>Prieto, Patricia ; Rosales-Mendoza, César Eduardo ; Terrón, Verónica ; Toledano, Víctor ; Cuadrado, Antonio ; López-Collazo, Eduardo ; Bannenberg, Gerard ; Martín-Sanz, Paloma ; Fernández-Velasco, María ; Boscá, Lisardo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c534t-aee34bc0cc1e8be63af3906d1ccffb77e0a16b22f4dbe68586e2007aca3390573</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>15-epi-lipoxin-A</topic><topic>Animals</topic><topic>Apoptosis - physiology</topic><topic>Autophagy - genetics</topic><topic>Autophagy - physiology</topic><topic>Basic Research Papers</topic><topic>Cytokines - metabolism</topic><topic>Docosahexaenoic Acids - metabolism</topic><topic>Half-Life</topic><topic>inflammation</topic><topic>Inflammation - metabolism</topic><topic>Lipoxins - metabolism</topic><topic>Macrophages - cytology</topic><topic>macrophages resolution</topic><topic>Mice, Inbred BALB C</topic><topic>Mice, Inbred C57BL</topic><topic>Mice, Knockout</topic><topic>resolvin-D1</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Prieto, Patricia</creatorcontrib><creatorcontrib>Rosales-Mendoza, César Eduardo</creatorcontrib><creatorcontrib>Terrón, Verónica</creatorcontrib><creatorcontrib>Toledano, Víctor</creatorcontrib><creatorcontrib>Cuadrado, Antonio</creatorcontrib><creatorcontrib>López-Collazo, Eduardo</creatorcontrib><creatorcontrib>Bannenberg, Gerard</creatorcontrib><creatorcontrib>Martín-Sanz, Paloma</creatorcontrib><creatorcontrib>Fernández-Velasco, María</creatorcontrib><creatorcontrib>Boscá, Lisardo</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Autophagy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Prieto, Patricia</au><au>Rosales-Mendoza, César Eduardo</au><au>Terrón, Verónica</au><au>Toledano, Víctor</au><au>Cuadrado, Antonio</au><au>López-Collazo, Eduardo</au><au>Bannenberg, Gerard</au><au>Martín-Sanz, Paloma</au><au>Fernández-Velasco, María</au><au>Boscá, Lisardo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Activation of autophagy in macrophages by pro-resolving lipid mediators</atitle><jtitle>Autophagy</jtitle><addtitle>Autophagy</addtitle><date>2015-10-03</date><risdate>2015</risdate><volume>11</volume><issue>10</issue><spage>1729</spage><epage>1744</epage><pages>1729-1744</pages><issn>1554-8627</issn><issn>1554-8635</issn><eissn>1554-8635</eissn><abstract>The resolution of inflammation is an active process driven by specialized pro-resolving lipid mediators, such as 15-epi-LXA 4 and resolvin D1 (RvD1), that promote tissue regeneration. Macrophages regulate the innate immune response being key players during the resolution phase to avoid chronic inflammatory pathologies. Their half-life is tightly regulated to accomplish its phagocytic function, allowing the complete cleaning of the affected area. The balance between apoptosis and autophagy appears to be essential to control the survival of these immune cells within the inflammatory context. In the present work, we demonstrate that 15-epi-LXA 4 and RvD1 at nanomolar concentrations promote autophagy in murine and human macrophages. Both compounds induced the MAP1LC3-I to MAP1LC3-II processing and the degradation of SQSTM1 as well as the formation of MAP1LC3 + autophagosomes, a typical signature of autophagy. Furthermore, 15-epi-LXA 4 and RvD1 treatment favored the fusion of the autophagosomes with lysosomes, allowing the final processing of the autophagic vesicles. This autophagic response involves the activation of MAPK1 and NFE2L2 pathways, but by an MTOR-independent mechanism. Moreover, these pro-resolving lipids improved the phagocytic activity of macrophages via NFE2L2. Therefore, 15-epi-LXA 4 and RvD1 improved both survival and functionality of macrophages, which likely supports the recovery of tissue homeostasis and avoiding chronic inflammatory diseases.</abstract><cop>United States</cop><pub>Taylor &amp; Francis</pub><pmid>26506892</pmid><doi>10.1080/15548627.2015.1078958</doi><tpages>16</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1554-8627
ispartof Autophagy, 2015-10, Vol.11 (10), p.1729-1744
issn 1554-8627
1554-8635
1554-8635
language eng
recordid cdi_crossref_primary_10_1080_15548627_2015_1078958
source MEDLINE; EZB-FREE-00999 freely available EZB journals; PubMed Central
subjects 15-epi-lipoxin-A
Animals
Apoptosis - physiology
Autophagy - genetics
Autophagy - physiology
Basic Research Papers
Cytokines - metabolism
Docosahexaenoic Acids - metabolism
Half-Life
inflammation
Inflammation - metabolism
Lipoxins - metabolism
Macrophages - cytology
macrophages resolution
Mice, Inbred BALB C
Mice, Inbred C57BL
Mice, Knockout
resolvin-D1
title Activation of autophagy in macrophages by pro-resolving lipid mediators
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T13%3A37%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Activation%20of%20autophagy%20in%20macrophages%20by%20pro-resolving%20lipid%20mediators&rft.jtitle=Autophagy&rft.au=Prieto,%20Patricia&rft.date=2015-10-03&rft.volume=11&rft.issue=10&rft.spage=1729&rft.epage=1744&rft.pages=1729-1744&rft.issn=1554-8627&rft.eissn=1554-8635&rft_id=info:doi/10.1080/15548627.2015.1078958&rft_dat=%3Cproquest_cross%3E1728257110%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1728257110&rft_id=info:pmid/26506892&rfr_iscdi=true